Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 27535860 | HLA-DQB1 (HLA-DQB1) | haploidentical transplantation | NA | NA | NA | unclassified | |
| to analyze allele mismatches of hla- a, - b, - c, - drb1, - dqb1 and haplotype mismatch of donor- recipient pairs on the outcome of haploidentical transplantation combined with a third part cord blood unit. | |||||||
| 27715384 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | cyclophosphamide | NA | melphalan | NA | unclassified | |
| NA | |||||||
| 27756586 | HLA (HLA) | hematopoietic stem cell transplantation | Croatian | NA | NA | unclassified | |
| the effect of hla allele and haplotype polymorphisms on donor matching in hematopoietic stem cell transplantation - croatian experience. | |||||||
| 27795530 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| long survival is obtained in 30-40% of adult t-cell leukemia-lymphoma (atl) patients with allogeneic hematopoietic stem cell transplantation (allo-hsct) using hla-matched related or unrelated donors. | |||||||
| 27795530 | HLA MATCHED (HLA-MATCHED) | adult t-cell leukemia-lymphoma | NA | NA | NA | unclassified | |
| long survival is obtained in 30-40% of adult t-cell leukemia-lymphoma (atl) patients with allogeneic hematopoietic stem cell transplantation (allo-hsct) using hla-matched related or unrelated donors. | |||||||
| 27829721 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| hematopoietic stem cell transplantation (hsct) is the treatment of choice when an appropriate human leukocyte antigen-matched donor is available. | |||||||
| 27858211 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| hematopoietic stem cell transplantation is used to treat fa, and best results are attained with sibling donors who are human leukocyte antigen (hla) identical matches. | |||||||
| 27872737 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | cyclophosphamide | NA | negation | |
| the advantage of using a human leukocyte antigen (hla)-mismatched related donor is that almost every patient who does not have an hla-identical donor or who urgently needs hematopoietic stem cell transplantation (hsct) has at least one family member with whom shares one haplotype (haploidentical) and who is promptly available as a donor. | |||||||
| 27905258 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| sto clarify optimal strategies for human leukocyte antigen (hla)-mismatched haploidentical hematopoietic stem cell transplantation (hsct). | |||||||
| 27905258 | HLA MISMATCHED (HLA-MISMATCHED) | haploidentical transplantation | NA | NA | NA | unclassified | |
| hla-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (atg: thymoglobulin). | |||||||
Copyright 2024